BARD1 antibody
Principal name
BARD1 antibody
Alternative names for BARD1 antibody
BARD-1, BRCA1-associated RING domain protein 1
Ncbi ID
9606, NP_000456.2, NP_000456, NP_031551.1, NM_022622, NM_000465
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Paraffin Sections (P), Western blot / Immunoblot (WB)
Background of BARD1 antibody
Mutations within the BRCA1 gene, localized to chromosome 17q, are believed to account for approximately 45% of families with increased incidence of both early-onset breast cancer and ovarian cancer. The BRCA1 gene is expressed in numerous tissues, including breast and ovary, and encodes a predicted protein of 1863 amino acids. This protein contains a RING domain near the N-terminus and appears to encode a tumor suppressor. BARD1 (BRCA1-associated RING domain protein 1) and BAP1 (BRCA1-associated protein 1) have both been shown to bind to the N-terminus of BRCA1 and are potential mediators of tumor suppression. BARD1 contains an N-terminal RING domain and three tandem ankyrin repeats. The C-terminus of BARD1 contains a region with sequence homology to BRCA1, termed the BRCT domain. BAP1 is an ubiquitin hydrolase and has been shown to enhance BRCA1-mediated cell growth suppression.






Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA313499 | BARD1 antibody |
||||||
| Rabbit polyclonal anti-BARD1 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu | WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| AP07899PU-N | BARD1 (108-124) antibody |
||||||
![]() |
Rabbit | Purified | Hu | E, P |
50 µg /
€425.00
|
||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
| AP20481PU-N | BARD1 antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu | P, WB |
0.1 mg /
€370.00
|
||
| OriGene Technologies GmbH | |||||||
| AP50339PU-N | BARD1 (N-term) antibody |
||||||
![]() |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR203817L1V | Lenti ORF particles, Bard1 (Myc-DDK-tagged ORF) - Rat BRCA1 associated RING domain 1 (Bard1), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,400.00
|
|
| OriGene Technologies, Inc. | ||





+1 additional image


